ACULAR LS (ketorolac tromethamine) Abbvie Patent: 9,216,167 Expiration: May 28, 2024 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of May 26, 2024 Read Post »
Annual Drug Patent Expirations for ENTRESTO Entresto is a drug marketed by Novartis Pharms Corp and is included in one
New patent expiration for Novartis Pharms drug ENTRESTO Read Post »
Annual Drug Patent Expirations for OXAYDO Oxaydo is a drug marketed by Zyla and is included in one NDA. It
Annual Drug Patent Expirations for CHILDREN%27S+ADVIL-FLAVORED For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
New patent expiration for Haleon Us drug CHILDREN’S ADVIL-FLAVORED Read Post »
Annual Drug Patent Expirations for MIRVASO Mirvaso is a drug marketed by Galderma Labs Lp and is included in one
New patent expiration for Galderma Labs drug MIRVASO Read Post »
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Abbvie and is included in one NDA. It
Annual Drug Patent Expirations for CHILDREN%27S+ADVIL+ALLERGY+SINUS For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
New patent expiration for Haleon Us drug CHILDREN’S ADVIL ALLERGY SINUS Read Post »
Annual Drug Patent Expirations for ORENITRAM Orenitram is a drug marketed by United Therap and is included in one NDA.
New patent expiration for United Therap drug ORENITRAM Read Post »
Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs.
New patent expiration for United Therap drug REMODULIN Read Post »
Get fresh news and insights, drug patent expirations & more…
